Published in Hepatology on March 01, 2009
19 Versus 22-Gauge Needle for EUS-LB (EUSLB1922) | NCT02967991
A New Track Ablation Device for Liver Biopsy: A Feasibility Study | NCT02521129
Endoscopic Ultrasound Guided Liver Biopsy | NCT03307811
Comparison of 19g FNA and 19g FNB Needles for EUS-LB | NCT03408171
Liver Biopsy Using a 19 Gauge Fine Needle Biopsy Needle | NCT03910790
Endoscopic Ultrasound vs Percutaneous Route for Biopsy | NCT04003766
Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial. Clin Gastroenterol Hepatol (2010) 2.96
Endpoints and clinical trial design for nonalcoholic steatohepatitis. Hepatology (2011) 2.44
KASL Clinical Practice Guidelines: Management of chronic hepatitis B. Clin Mol Hepatol (2012) 2.10
Elevated serum ferritin. JAMA (2014) 2.04
Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: a prospective study. Hepatology (2014) 2.00
An update on the management of chronic hepatitis C: 2015 Consensus guidelines from the Canadian Association for the Study of the Liver. Can J Gastroenterol Hepatol (2015) 1.86
Noninvasive Diagnosis of Nonalcoholic Fatty Liver Disease and Quantification of Liver Fat Using a New Quantitative Ultrasound Technique. Clin Gastroenterol Hepatol (2014) 1.75
Non-high-density lipoprotein cholesterol as a biomarker for nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol (2012) 1.74
AASLD clinical practice guidelines: a critical review of scientific evidence and evolving recommendations. Hepatology (2013) 1.64
The precarious state of the liver after a Fontan operation: summary of a multidisciplinary symposium. Pediatr Cardiol (2012) 1.62
The indications for liver biopsy. Dtsch Arztebl Int (2012) 1.60
An update on the management of hepatitis C: consensus guidelines from the Canadian Association for the Study of the Liver. Can J Gastroenterol (2012) 1.57
Physicians' practices for diagnosing liver fibrosis in chronic liver diseases: a nationwide, Canadian survey. Can J Gastroenterol Hepatol (2014) 1.37
Prevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challenges. Curr Cancer Drug Targets (2012) 1.23
Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. World J Gastroenterol (2014) 1.20
Inflammatory pseudotumor of the liver: a case report and review of the literature. J Med Case Rep (2011) 1.18
The osteopontin level in liver, adipose tissue and serum is correlated with fibrosis in patients with alcoholic liver disease. PLoS One (2012) 1.17
A new model using routinely available clinical parameters to predict significant liver fibrosis in chronic hepatitis B. PLoS One (2011) 1.16
Shear wave velocity is a useful marker for managing nonalcoholic steatohepatitis. World J Gastroenterol (2010) 1.15
Percutaneous liver biopsy practice patterns among Canadian hepatologists. Can J Gastroenterol (2013) 1.15
Obesity-dependent metabolic signatures associated with nonalcoholic fatty liver disease progression. J Proteome Res (2012) 1.14
Complications of percutaneous liver biopsy with Klatskin needles: a 36-year single-centre experience. Aliment Pharmacol Ther (2017) 1.14
Prognostic value of Ishak fibrosis stage: findings from the hepatitis C antiviral long-term treatment against cirrhosis trial. Hepatology (2010) 1.12
Quantitative liver function tests improve the prediction of clinical outcomes in chronic hepatitis C: results from the Hepatitis C Antiviral Long-term Treatment Against Cirrhosis Trial. Hepatology (2012) 1.12
Mass-encoded synthetic biomarkers for multiplexed urinary monitoring of disease. Nat Biotechnol (2012) 1.10
KASL clinical practice guidelines: management of nonalcoholic fatty liver disease. Clin Mol Hepatol (2013) 1.08
KASL clinical practice guidelines: management of chronic hepatitis B. Clin Mol Hepatol (2016) 1.07
Rate of progression of hepatic fibrosis in patients with chronic hepatitis C: results from the HALT-C Trial. Gastroenterology (2011) 1.07
Primary lymphoma of the liver - A complex diagnosis. World J Radiol (2012) 1.07
MRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: Clinical trials to clinical practice. J Hepatol (2016) 1.06
Hepatic inflammation and progressive liver fibrosis in chronic liver disease. World J Gastroenterol (2014) 1.06
Non-invasive diagnosis of liver fibrosis in chronic hepatitis C. World J Gastroenterol (2014) 1.05
Transient elastography: Kill two birds with one stone? World J Hepatol (2013) 1.03
Transient elastography for the noninvasive assessment of liver fibrosis: a multicentre Canadian study. Can J Gastroenterol (2010) 1.02
Liver stiffness by transient elastography predicts liver-related complications and mortality in patients with chronic liver disease. PLoS One (2014) 1.02
High hepatitis B surface antigen levels predict insignificant fibrosis in hepatitis B e antigen positive chronic hepatitis B. PLoS One (2012) 1.01
Improving hepatocellular carcinoma screening: applying lessons from colorectal cancer screening. Clin Gastroenterol Hepatol (2012) 1.01
Non invasive tools for the diagnosis of liver cirrhosis. World J Gastroenterol (2014) 1.00
Safety and effectiveness of blind percutaneous liver biopsy: analysis of 1412 procedures. Hepat Mon (2012) 1.00
MR relaxometry of the liver: significant elevation of T1 relaxation time in patients with liver cirrhosis. Eur Radiol (2012) 0.99
Liver involvement in subjects with rheumatic disease. Arthritis Res Ther (2011) 0.98
Liver biopsy in modern clinical practice: a pediatric point-of-view. Adv Anat Pathol (2012) 0.98
Prospective evaluation of the diagnostic accuracy of hepatic copper content, as determined using the entire core of a liver biopsy sample. Hepatology (2015) 0.98
Coffee consumption in NAFLD patients with lower insulin resistance is associated with lower risk of severe fibrosis. Liver Int (2013) 0.97
Fixation methods for electron microscopy of human and other liver. World J Gastroenterol (2010) 0.97
Correlation of serum liver fibrosis markers with severity of liver dysfunction in liver cirrhosis: a retrospective cross-sectional study. Int J Clin Exp Med (2015) 0.96
Hepatocellular Carcinoma in the Absence of Cirrhosis in United States Veterans Is Associated With Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol (2015) 0.96
Co-existence of non-alcoholic fatty liver disease and inflammatory bowel disease: A review article. World J Gastroenterol (2016) 0.95
Liver biopsy for histological assessment: The case against. Saudi J Gastroenterol (2010) 0.94
S-adenosyl-L-methionine treatment for alcoholic liver disease: a double-blinded, randomized, placebo-controlled trial. Alcohol Clin Exp Res (2011) 0.94
Non-invasive evaluation of liver fibrosis: a comparison of ultrasound-based transient elastography and MR elastography in patients with viral hepatitis B and C. Eur Radiol (2013) 0.94
The feasibility and reliability of transient elastography using Fibroscan®: a practice audit of 2335 examinations. Can J Gastroenterol Hepatol (2014) 0.94
Gene expression analysis in serial liver fine needle aspirates. J Viral Hepat (2014) 0.93
Non-contrasted computed tomography for the accurate measurement of liver steatosis in obese patients. Dig Dis Sci (2011) 0.93
A comparison of MR elastography and 31P MR spectroscopy with histological staging of liver fibrosis. Eur Radiol (2012) 0.92
Chronic hepatitis C and liver fibrosis. World J Gastroenterol (2014) 0.92
Histogram analysis of gadoxetic acid-enhanced MRI for quantitative hepatic fibrosis measurement. PLoS One (2014) 0.91
Nonalcoholic Fatty Liver Disease: Pathophysiology and Management. Gastroenterol Clin North Am (2016) 0.90
Management of chronic hepatitis B with nucleoside or nucleotide analogues: a review of current guidelines. Gut Liver (2010) 0.90
Liver stiffness measurement among patients with chronic hepatitis B and C: results from a 5-year prospective study. PLoS One (2014) 0.90
Transient elastography to assess hepatic fibrosis in hemodialysis chronic hepatitis C patients. Clin J Am Soc Nephrol (2011) 0.90
FibroSURE and FibroScan in relation to treatment response in chronic hepatitis C virus. World J Gastroenterol (2011) 0.90
OxNASH score correlates with histologic features and severity of nonalcoholic fatty liver disease. Dig Dis Sci (2014) 0.89
Management of liver cirrhosis between primary care and specialists. World J Gastroenterol (2011) 0.89
Potential applications of thromboelastography in patients with acute and chronic liver disease. Gastroenterol Hepatol (N Y) (2012) 0.88
Noninvasive Diagnosis of NASH and Liver Fibrosis Within the Spectrum of NAFLD. Gastroenterol Hepatol (N Y) (2012) 0.87
Percutaneous ultrasonographically guided liver punctures: an analysis of 1961 patients over a period of ten years. BMC Gastroenterol (2012) 0.87
Polyunsaturated fatty acid metabolites as novel lipidomic biomarkers for noninvasive diagnosis of nonalcoholic steatohepatitis. J Lipid Res (2014) 0.87
Laparoscopic liver biopsy in the diagnosis of hepatic epithelioid hemangioendothelioma: A case report. Oncol Lett (2014) 0.87
Non-invasive diagnosis of hepatitis B virus-related cirrhosis. World J Gastroenterol (2014) 0.87
Accuracy of routine clinical ultrasound for staging of liver fibrosis. J Clin Imaging Sci (2012) 0.86
Diagnostic accuracy of two-dimensional shear wave elastography for the non-invasive staging of hepatic fibrosis in chronic hepatitis B: a cohort study with internal validation. Eur Radiol (2014) 0.86
Clinical Management of Chronic Portal/Mesenteric Vein Thrombosis: The Surgeon's Point of View. Viszeralmedizin (2014) 0.86
Serum ceruloplasmin levels correlate negatively with liver fibrosis in males with chronic hepatitis B: a new noninvasive model for predicting liver fibrosis in HBV-related liver disease. PLoS One (2013) 0.86
Non-invasive histologic markers of liver disease in patients with chronic hepatitis B. Hepat Mon (2014) 0.85
A new metabolism-related index correlates with the degree of liver fibrosis in hepatitis C virus-positive patients. Gastroenterol Res Pract (2015) 0.84
Accuracy of ultrasound and noninvasive markers of fibrosis to identify patients with cirrhosis. Dig Dis Sci (2015) 0.84
Magnetic resonance-based total liver volume and magnetic resonance-diffusion weighted imaging for staging liver fibrosis in mini-pigs. World J Gastroenterol (2012) 0.84
Occult hepatitis C virus infection in candidates for liver transplant with cryptogenic cirrhosis. Hepat Mon (2013) 0.84
A comparison of liver sampling techniques in dogs. J Vet Intern Med (2014) 0.83
Circulating microRNAs as biomarkers in hepatocellular carcinoma screening: a validation set from China. Medicine (Baltimore) (2015) 0.83
Noninvasive assessment of liver fibrosis in patients with chronic hepatitis B. World J Gastroenterol (2014) 0.83
Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver disease. World J Gastroenterol (2016) 0.83
Utility of Platelet Count for Predicting Cirrhosis in Alcoholic Liver Disease: Model for Identifying Cirrhosis in a US Population. J Gen Intern Med (2015) 0.83
Cost-Effective Evaluation of Nonalcoholic Fatty Liver Disease With NAFLD Fibrosis Score and Vibration Controlled Transient Elastography. Am J Gastroenterol (2015) 0.82
Prediction of the Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Patients after Sustained Virological Response by Aspartate Aminotransferase to Platelet Ratio Index. Gut Liver (2016) 0.82
Fontan Liver Disease: Review of an Emerging Epidemic and Management Options. Curr Treat Options Cardiovasc Med (2015) 0.82
High Prevalence of Nonalcoholic Fatty Liver Disease in Adolescents Undergoing Bariatric Surgery. Gastroenterology (2015) 0.81
Magnetic Resonance Elastography for the Evaluation of Liver Fibrosis in Chronic Hepatitis B and C by Using Both Gradient-Recalled Echo and Spin-Echo Echo Planar Imaging: A Prospective Study. Am J Gastroenterol (2016) 0.81
Endoscopic ultrasound-guided liver biopsy. Endosc Ultrasound (2015) 0.81
Can Serum ST2 Levels Be Used as a Marker of Fibrosis in Chronic Hepatitis B Infection? Medicine (Baltimore) (2015) 0.81
Prognostic Value of Non-Invasive Fibrosis and Steatosis Tools, Hepatic Venous Pressure Gradient (HVPG) and Histology in Nonalcoholic Steatohepatitis. PLoS One (2015) 0.81
Endoscopic ultrasound-guided liver biopsy: a multicenter experience. Endosc Int Open (2015) 0.81
Use of Wisteria Floribunda Agglutinin-Positive Human Mac-2 Binding Protein in Assessing Risk of Hepatocellular Carcinoma Due to Hepatitis B Virus. Medicine (Baltimore) (2016) 0.81
Relationship between Controlled Attenuation Parameter and Hepatic Steatosis as Assessed by Ultrasound in Alcoholic or Nonalcoholic Fatty Liver Disease. Gut Liver (2016) 0.81
Clinical advances in pediatric nonalcoholic fatty liver disease. Hepatology (2016) 0.81
Liver lobe volumes and the ratios of liver lobe volumes to spleen volume on magnetic resonance imaging for staging liver fibrosis in a minipig model. PLoS One (2013) 0.80
The diagnostic efficacy of quantitative liver MR imaging with diffusion-weighted, SWI, and hepato-specific contrast-enhanced sequences in staging liver fibrosis-a multiparametric approach. Eur Radiol (2015) 0.80
Translating an understanding of the pathogenesis of hepatic fibrosis to novel therapies. Clin Gastroenterol Hepatol (2013) 0.80
Cost-utility analysis of nonalcoholic steatohepatitis screening. Eur Radiol (2015) 0.80
Management of hepatocellular carcinoma: an update. Hepatology (2011) 33.57
Diagnosis, management, and treatment of hepatitis C: an update. Hepatology (2009) 22.53
Boceprevir for untreated chronic HCV genotype 1 infection. N Engl J Med (2011) 19.01
Boceprevir for previously treated chronic HCV genotype 1 infection. N Engl J Med (2011) 12.09
Diagnosis, management, and treatment of hepatitis C. Hepatology (2004) 11.62
Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology (2003) 8.75
Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease. Gastroenterology (2008) 6.15
The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology (2012) 5.47
Diagnosis and management of autoimmune hepatitis. Hepatology (2010) 5.27
Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment. Gastroenterology (2004) 4.27
Disparities in liver transplantation before and after introduction of the MELD score. JAMA (2008) 4.10
Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis. Hepatology (2014) 4.01
Diagnosis and management of primary sclerosing cholangitis. Hepatology (2010) 3.60
AASLD guidelines for treatment of chronic hepatitis B. Hepatology (2015) 3.32
Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace. J Hepatol (2012) 2.89
The Role of Transjugular Intrahepatic Portosystemic Shunt (TIPS) in the Management of Portal Hypertension: update 2009. Hepatology (2010) 2.83
Endoscopic cyanoacrylate versus transjugular intrahepatic portosystemic shunt for gastric variceal bleeding: a single-center U.S. analysis. Gastrointest Endosc (2009) 2.63
Hemostasis and thrombosis in patients with liver disease: the ups and downs. J Hepatol (2010) 2.41
Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method. Hepatology (2010) 2.30
Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology (2011) 2.28
The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension. Hepatology (2005) 2.28
Dual-energy multidetector CT: how does it work, what can it tell us, and when can we use it in abdominopelvic imaging? Radiographics (2010) 2.27
Epidemiology and natural history of non-alcoholic steatohepatitis. Clin Liver Dis (2009) 2.22
Intensive care of patients with acute liver failure: recommendations of the U.S. Acute Liver Failure Study Group. Crit Care Med (2007) 2.17
Glycogen storage disease type III diagnosis and management guidelines. Genet Med (2010) 2.13
Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis. J Hepatol (2009) 2.06
Evaluation for liver transplantation: adherence to AASLD referral guidelines in a large Veterans Affairs center. Liver Transpl (2005) 2.06
Journal Club: incidental thyroid nodules detected at imaging: can diagnostic workup be reduced by use of the Society of Radiologists in Ultrasound recommendations and the three-tiered system? AJR Am J Roentgenol (2014) 2.05
Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C. Hepatology (2008) 2.02
Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohort. Hepatology (2005) 1.93
Effects of aerobic vs. resistance training on visceral and liver fat stores, liver enzymes, and insulin resistance by HOMA in overweight adults from STRRIDE AT/RT. Am J Physiol Endocrinol Metab (2011) 1.91
Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the European Association for the Study of the Liver and the American Association for the Study of Liver Diseases. J Hepatol (2014) 1.84
Diagnosis and management of hemochromatosis. Hepatology (2001) 1.81
Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis C. Gut (2010) 1.78
Acoustic radiation force impulse imaging of the abdomen: demonstration of feasibility and utility. Ultrasound Med Biol (2005) 1.73
Position statement: Nonanesthesiologist administration of propofol for GI endoscopy. Gastroenterology (2009) 1.67
The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Am J Gastroenterol (2012) 1.61
Making the diagnosis of acute appendicitis: do more preoperative CT scans mean fewer negative appendectomies? A 10-year study. Radiology (2010) 1.60
Giant cell tumor of the extrahepatic biliary tree: a clinicopathologic study of 4 cases and comparison with anaplastic spindle and giant cell carcinoma with osteoclast-like giant cells. Am J Surg Pathol (2006) 1.58
Kinetics of hepatitis B surface antigen decline during 3 years of telbivudine treatment in hepatitis B e antigen-positive patients. Hepatology (2010) 1.55
Retransplantation for hepatitis C: results of a U.S. multicenter retransplant study. Liver Transpl (2007) 1.54
Bleeding and thrombosis in cirrhotic patients: what really matters? Dig Liver Dis (2011) 1.54
Central venous catheter integrity during mechanical power injection of iodinated contrast medium. Radiology (2009) 1.53
Complications of laparoscopic and percutaneous renal cryoablation in a single tertiary referral center. Eur Urol (2010) 1.53
Pancreatic FNA in 1000 cases: a comparison of imaging modalities. Gastrointest Endosc (2005) 1.52
Thiazolidinediones for the treatment in NASH: sustained benefit after drug discontinuation? J Clin Gastroenterol (2009) 1.47
Prophylactic anticoagulation for venous thromboembolism in hospitalized cirrhosis patients is not associated with high rates of gastrointestinal bleeding. Liver Int (2013) 1.47
Sorafenib therapy for hepatocellular carcinoma prior to liver transplant is associated with increased complications after transplant. Transpl Int (2011) 1.46
Hypervascular liver tumors: low tube voltage, high tube current multi-detector row CT for enhanced detection--phantom study. Radiology (2008) 1.44
ACR Appropriateness Criteria® acute pancreatitis. Ultrasound Q (2014) 1.44
Hepatic HCV RNA before and after treatment with interferon alone or combined with ribavirin. Hepatology (2002) 1.40
Intermittent disconjugate gaze: a novel finding in nonalcoholic steatohepatitis and cryptogenic cirrhosis. Hepatology (2005) 1.39
Acute appendicitis: added diagnostic value of coronal reformations from isotropic voxels at multi-detector row CT. Radiology (2005) 1.37
Helical CT for nephrolithiasis and ureterolithiasis: comparison of conventional and reduced radiation-dose techniques. Radiology (2003) 1.35
Emerging applications for ferumoxytol as a contrast agent in MRI. J Magn Reson Imaging (2014) 1.35
Hypervascular liver tumors: low tube voltage, high tube current multidetector CT during late hepatic arterial phase for detection--initial clinical experience. Radiology (2009) 1.34
The Gastroenterology Core Curriculum, Third Edition. Gastroenterology (2007) 1.31
Training the gastroenterologist of the future: the Gastroenterology Core Curriculum. Gastroenterology (2003) 1.29
Coagulopathy does not fully protect hospitalized cirrhosis patients from peripheral venous thromboembolism. Am J Gastroenterol (2006) 1.27
Final results of a double-blind, placebo-controlled trial of the antifibrotic efficacy of interferon-gamma1b in chronic hepatitis C patients with advanced fibrosis or cirrhosis. Hepatology (2007) 1.27
Hepatic decompensation likely attributable to simeprevir in patients with advanced cirrhosis. Dig Dis Sci (2014) 1.27
Children with autism are neither systematic nor optimal foragers. Proc Natl Acad Sci U S A (2010) 1.25
Coagulation in liver disease: a guide for the clinician. Clin Gastroenterol Hepatol (2013) 1.24
Comparison of MR cholangiopancreatographic techniques with contrast-enhanced cholangiography in the evaluation of sclerosing cholangitis. AJR Am J Roentgenol (2002) 1.23
Associations of depression, anxiety and antidepressants with histological severity of nonalcoholic fatty liver disease. Liver Int (2013) 1.22
Long-term medical management of the pediatric patient after liver transplantation: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Liver Transpl (2013) 1.19
Best practices in diagnostic immunohistochemistry: hepatocellular carcinoma versus metastatic neoplasms. Arch Pathol Lab Med (2007) 1.19
State of the art: dual-energy CT of the abdomen. Radiology (2014) 1.17
Impact of dual-energy multi-detector row CT with virtual monochromatic imaging on renal cyst pseudoenhancement: in vitro and in vivo study. Radiology (2014) 1.16
In vivo guidance and assessment of liver radio-frequency ablation with acoustic radiation force elastography. Ultrasound Med Biol (2008) 1.13
Prognostic value of Ishak fibrosis stage: findings from the hepatitis C antiviral long-term treatment against cirrhosis trial. Hepatology (2010) 1.12
Liver biopsy in cirrhotic patients. Am J Gastroenterol (2007) 1.10
Cardiohepatic interactions in heart failure: an overview and clinical implications. J Am Coll Cardiol (2013) 1.10
Complications after percutaneous radiofrequency ablation of renal tumors. Urology (2005) 1.10
Dual-energy multi-detector row CT with virtual monochromatic imaging for improving patient-to-patient uniformity of aortic enhancement during CT angiography: an in vitro and in vivo study. Radiology (2014) 1.09
Autoimmune hepatitis. Lancet (2013) 1.09
Practice patterns in percutaneous image-guided intraabdominal abscess drainage: survey of academic and private practice centers. Radiology (2004) 1.08
Rate of progression of hepatic fibrosis in patients with chronic hepatitis C: results from the HALT-C Trial. Gastroenterology (2011) 1.07
Radiation dose reduction in abdominal computed tomography during the late hepatic arterial phase using a model-based iterative reconstruction algorithm: how low can we go? Invest Radiol (2012) 1.07
Radiation dose savings for adult pulmonary embolus 64-MDCT using bismuth breast shields, lower peak kilovoltage, and automatic tube current modulation. AJR Am J Roentgenol (2009) 1.05
Dual-energy CT applications in the abdomen. AJR Am J Roentgenol (2012) 1.05
Diabetic hepatosclerosis: diabetic microangiopathy of the liver. Arch Pathol Lab Med (2006) 1.02
Expression of perilipin and adipophilin in nonalcoholic fatty liver disease; relevance to oxidative injury and hepatocyte ballooning. J Atheroscler Thromb (2009) 1.02
Combination of N-acetylcysteine and metformin improves histological steatosis and fibrosis in patients with non-alcoholic steatohepatitis. Hepatol Res (2008) 1.02
Calcifying nested stromal-epithelial tumors of the liver: a clinicopathologic, immunohistochemical, and molecular genetic study of 9 cases with a long-term follow-up. Am J Surg Pathol (2009) 1.01
Pathologic assessment of non-alcoholic fatty liver disease. Clin Liver Dis (2007) 1.01
The zonal distribution of megamitochondria with crystalline inclusions in nonalcoholic steatohepatitis. Hepatology (2004) 1.00
Detection of pancreatic tumors, image quality, and radiation dose during the pancreatic parenchymal phase: effect of a low-tube-voltage, high-tube-current CT technique--preliminary results. Radiology (2010) 1.00
Optimization of eight-element multi-detector row helical CT technology for evaluation of the abdomen. Radiology (2003) 0.99
MDCT of patients with acute abdominal pain: a new perspective using coronal reformations from submillimeter isotropic voxels. AJR Am J Roentgenol (2004) 0.99
Dual gradient-echo in-phase and opposed-phase hepatic MR imaging: a useful tool for evaluating more than fatty infiltration or fatty sparing. Radiographics (2006) 0.99
Glypican-3 expression in benign liver tissue with active hepatitis C: implications for the diagnosis of hepatocellular carcinoma. Hum Pathol (2007) 0.99
A journey toward excellence: training future gastroenterologists--the gastroenterology core curriculum, third edition. Am J Gastroenterol (2007) 0.99
A rodent model of NASH with cirrhosis, oval cell proliferation and hepatocellular carcinoma. J Hepatol (2008) 0.98
Thin-section multidetector CT angiography of renal artery stents. AJR Am J Roentgenol (2002) 0.98
Body CT: technical advances for improving safety. AJR Am J Roentgenol (2011) 0.98
Primary gallbladder sarcoma: a clinicopathologic study of 15 cases, heterogeneous sarcomas with poor outcome, except pediatric botryoid rhabdomyosarcoma. Am J Surg Pathol (2009) 0.97